Table 1.
Demographic, laboratorial and clinical features of the study population.
| Groups | (n) | Sex | AgeMedian (Min-Max) | Bacilloscopic IndexMedian (Min-Max) | Number of LesionsMedian (Min-Max) | Affected Nerves Median (Min-Max) | |
|---|---|---|---|---|---|---|---|
| Malen (%) | Femalen (%) | ||||||
| NI | 18 | 8 (44.4) | 10 (55.6) | 39 (23-56) | - | - | - |
| HHC | 7 | 2 (28.6) | 5 (71.4) | 38 (21-54) | – | – | – |
| L(PB) | 14 | 6 (42.9) | 8 (57.1) | 39 (31-47) | 0 (0-0) | 1.0 (1-5) | 0 (0-3) |
| L(MB) | 13 | 7 (53.8) | 6 (46.2) | 48 (34-58) | 4.0 (2.5-5.5)* | 20 (7-20)* | 1.0 (0-3) |
| T1LR | 12 | 9 (75.0) | 3 (25) | 49 (21-62) | 0 (0-3.5) | 20 (1-30) | 2 (0-3) |
| T2LR | 11 | 10 (90.9) | 1 (9.1) | 45 (27-64) | 3.0 (2.8-5.0)** | 20 (20-30) | 2 (0-2) |
NI = Non-Infected healthy volunteers with no clinical history of leprosy; HHC = households contacts of Leprosy patients; L(PB) = Paucibacillary Leprosy; MB – Multibacillary Leprosy patients; T1LR – patients with Type 1 Leprosy Reaction; T2LR – patients with Type 2 Leprosy Reaction. No significant difference was observed for age distribution by Kruskal-Wallis (p= 0.0714). No significant difference was observed for sex distribution by Chi-square Test (p=0.0633). *Higher bacilloscopic index and number of lesions were observed in L(MB) as compared with L(PB) by Mann-Whitney test (p= 0,0002; p= 0,0008, respectively); **Higher bacilloscopic index was observed in T2LR as compared to T1LR by Mann-Whitney test (p= 0,0242).